Global Site Directed Mutagenesis Systems Market
Global Site Directed Mutagenesis Systems Market

Site Directed Mutagenesis Systems Comprehensive Study by Type (Single site directed mutagenesis, Multiple site directed mutagenesis), Application (Cancer, Diabetes, Cystic fibrosis), End-users (Research institutes, Hospitals, Diagnostic Laboratories), Device (Real time PCR, Inverse PCR) Players and Region - Global Market Outlook to 2026

Site Directed Mutagenesis Systems Market Segmented into XX Submarkets. | Forecast Years: 2021- 2026  

Apr 2021 Edition 233 Pages 216 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
What is Site Directed Mutagenesis Systems Market?

Site-directed mutagenesis (SDM) is a method to create specific, targeted changes in double-stranded plasmid DNA for many reasons such as to study changes in protein activity that occur as a result of the DNA manipulation, to select or screen for mutations (at the DNA, RNA or protein level) that have the desired property and introduce or remove restriction endonuclease sites or tags. Site-Directed Mutagenesis System provides a state-of-the-art, simple, convenient, and highly efficient means to generate mutations on a target construct in vitro in less than three hours. The factors such as Increased Prevalence of Chronic Diseases and Rise in the Number of Alteration Sites are the key drivers for the global Site-Directed Mutagenesis Systems market. However, Bann on Cloning Practices and Disadvantages such as Antibiotic Resistance may hamper the market growth.

The market study is being classified by Type (Single site directed mutagenesis and Multiple site directed mutagenesis), by Application (Cancer, Diabetes and Cystic fibrosis) and major geographies with country level break-up.

Thermo Fisher Scientific (United States), Takara Bio Inc. (Japan), Genomax Technologies Pvt. Ltd. (Singapore), Agilent Technologies Inc. (United States) and Transgen Biotech Co. Ltd (Japan) are some of the key players profiled in the study.

The companies are exploring the market by adopting expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to gain competitive advantage through combined collaborations. Research Analyst at AMA predicts that United States and Japanese Players will contribute to the maximum growth of Global Site Directed Mutagenesis Systems market throughout the predicted period.

Segment Analysis
Analyst at AMA have segmented the market study of Global Site Directed Mutagenesis Systems market by Type, Application and Region.

On the basis of geography, the market of Site Directed Mutagenesis Systems has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Drivers
  • Increased Prevalence of Chronic Diseases
  • Rise in the Number of Alteration Sites

Market Trend
  • Technological Advancements in the Healthcare Sector

Restraints
  • Bann on Cloning Practices

Opportunities
  • Growth in the Healthcare Industry Worldwide
  • Increasing Demand from End-users

Challenges
  • Disadvantages such as Antibiotic Resistance





Key Target Audience
Site Directed Mutagenesis Systems Developers, Emerging Companies, Research Professionals and End-users

Customization in the Report Available:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase
Report Objectives / Segmentation Covered
By Type
  • Single site directed mutagenesis
  • Multiple site directed mutagenesis
By Application
  • Cancer
  • Diabetes
  • Cystic fibrosis
By End-users
  • Research institutes
  • Hospitals
  • Diagnostic Laboratories

By Device
  • Real time PCR
  • Inverse PCR

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increased Prevalence of Chronic Diseases
      • 3.2.2. Rise in the Number of Alteration Sites
    • 3.3. Market Challenges
      • 3.3.1. Disadvantages such as Antibiotic Resistance
    • 3.4. Market Trends
      • 3.4.1. Technological Advancements in the Healthcare Sector
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Site Directed Mutagenesis Systems, by Type, Application, End-users, Device and Region (value) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Site Directed Mutagenesis Systems (Value)
      • 5.2.1. Global Site Directed Mutagenesis Systems by: Type (Value)
        • 5.2.1.1. Single site directed mutagenesis
        • 5.2.1.2. Multiple site directed mutagenesis
      • 5.2.2. Global Site Directed Mutagenesis Systems by: Application (Value)
        • 5.2.2.1. Cancer
        • 5.2.2.2. Diabetes
        • 5.2.2.3. Cystic fibrosis
      • 5.2.3. Global Site Directed Mutagenesis Systems by: End-users (Value)
        • 5.2.3.1. Research institutes
        • 5.2.3.2. Hospitals
        • 5.2.3.3. Diagnostic Laboratories
      • 5.2.4. Global Site Directed Mutagenesis Systems by: Device (Value)
        • 5.2.4.1. Real time PCR
        • 5.2.4.2. Inverse PCR
      • 5.2.5. Global Site Directed Mutagenesis Systems Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
  • 6. Site Directed Mutagenesis Systems: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Thermo Fisher Scientific (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Takara Bio Inc. (Japan)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Genomax Technologies Pvt. Ltd. (Singapore)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Agilent Technologies Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Transgen Biotech Co. Ltd (Japan)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
  • 7. Global Site Directed Mutagenesis Systems Sale, by Type, Application, End-users, Device and Region (value) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Site Directed Mutagenesis Systems (Value)
      • 7.2.1. Global Site Directed Mutagenesis Systems by: Type (Value)
        • 7.2.1.1. Single site directed mutagenesis
        • 7.2.1.2. Multiple site directed mutagenesis
      • 7.2.2. Global Site Directed Mutagenesis Systems by: Application (Value)
        • 7.2.2.1. Cancer
        • 7.2.2.2. Diabetes
        • 7.2.2.3. Cystic fibrosis
      • 7.2.3. Global Site Directed Mutagenesis Systems by: End-users (Value)
        • 7.2.3.1. Research institutes
        • 7.2.3.2. Hospitals
        • 7.2.3.3. Diagnostic Laboratories
      • 7.2.4. Global Site Directed Mutagenesis Systems by: Device (Value)
        • 7.2.4.1. Real time PCR
        • 7.2.4.2. Inverse PCR
      • 7.2.5. Global Site Directed Mutagenesis Systems Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Site Directed Mutagenesis Systems: by Type(USD Million)
  • Table 2. Site Directed Mutagenesis Systems Single site directed mutagenesis , by Region USD Million (2015-2020)
  • Table 3. Site Directed Mutagenesis Systems Multiple site directed mutagenesis , by Region USD Million (2015-2020)
  • Table 4. Site Directed Mutagenesis Systems: by Application(USD Million)
  • Table 5. Site Directed Mutagenesis Systems Cancer , by Region USD Million (2015-2020)
  • Table 6. Site Directed Mutagenesis Systems Diabetes , by Region USD Million (2015-2020)
  • Table 7. Site Directed Mutagenesis Systems Cystic fibrosis , by Region USD Million (2015-2020)
  • Table 8. Site Directed Mutagenesis Systems: by End-users(USD Million)
  • Table 9. Site Directed Mutagenesis Systems Research institutes , by Region USD Million (2015-2020)
  • Table 10. Site Directed Mutagenesis Systems Hospitals , by Region USD Million (2015-2020)
  • Table 11. Site Directed Mutagenesis Systems Diagnostic Laboratories , by Region USD Million (2015-2020)
  • Table 12. Site Directed Mutagenesis Systems: by Device(USD Million)
  • Table 13. Site Directed Mutagenesis Systems Real time PCR , by Region USD Million (2015-2020)
  • Table 14. Site Directed Mutagenesis Systems Inverse PCR , by Region USD Million (2015-2020)
  • Table 15. South America Site Directed Mutagenesis Systems, by Country USD Million (2015-2020)
  • Table 16. South America Site Directed Mutagenesis Systems, by Type USD Million (2015-2020)
  • Table 17. South America Site Directed Mutagenesis Systems, by Application USD Million (2015-2020)
  • Table 18. South America Site Directed Mutagenesis Systems, by End-users USD Million (2015-2020)
  • Table 19. South America Site Directed Mutagenesis Systems, by Device USD Million (2015-2020)
  • Table 20. Brazil Site Directed Mutagenesis Systems, by Type USD Million (2015-2020)
  • Table 21. Brazil Site Directed Mutagenesis Systems, by Application USD Million (2015-2020)
  • Table 22. Brazil Site Directed Mutagenesis Systems, by End-users USD Million (2015-2020)
  • Table 23. Brazil Site Directed Mutagenesis Systems, by Device USD Million (2015-2020)
  • Table 24. Argentina Site Directed Mutagenesis Systems, by Type USD Million (2015-2020)
  • Table 25. Argentina Site Directed Mutagenesis Systems, by Application USD Million (2015-2020)
  • Table 26. Argentina Site Directed Mutagenesis Systems, by End-users USD Million (2015-2020)
  • Table 27. Argentina Site Directed Mutagenesis Systems, by Device USD Million (2015-2020)
  • Table 28. Rest of South America Site Directed Mutagenesis Systems, by Type USD Million (2015-2020)
  • Table 29. Rest of South America Site Directed Mutagenesis Systems, by Application USD Million (2015-2020)
  • Table 30. Rest of South America Site Directed Mutagenesis Systems, by End-users USD Million (2015-2020)
  • Table 31. Rest of South America Site Directed Mutagenesis Systems, by Device USD Million (2015-2020)
  • Table 32. Asia Pacific Site Directed Mutagenesis Systems, by Country USD Million (2015-2020)
  • Table 33. Asia Pacific Site Directed Mutagenesis Systems, by Type USD Million (2015-2020)
  • Table 34. Asia Pacific Site Directed Mutagenesis Systems, by Application USD Million (2015-2020)
  • Table 35. Asia Pacific Site Directed Mutagenesis Systems, by End-users USD Million (2015-2020)
  • Table 36. Asia Pacific Site Directed Mutagenesis Systems, by Device USD Million (2015-2020)
  • Table 37. China Site Directed Mutagenesis Systems, by Type USD Million (2015-2020)
  • Table 38. China Site Directed Mutagenesis Systems, by Application USD Million (2015-2020)
  • Table 39. China Site Directed Mutagenesis Systems, by End-users USD Million (2015-2020)
  • Table 40. China Site Directed Mutagenesis Systems, by Device USD Million (2015-2020)
  • Table 41. Japan Site Directed Mutagenesis Systems, by Type USD Million (2015-2020)
  • Table 42. Japan Site Directed Mutagenesis Systems, by Application USD Million (2015-2020)
  • Table 43. Japan Site Directed Mutagenesis Systems, by End-users USD Million (2015-2020)
  • Table 44. Japan Site Directed Mutagenesis Systems, by Device USD Million (2015-2020)
  • Table 45. India Site Directed Mutagenesis Systems, by Type USD Million (2015-2020)
  • Table 46. India Site Directed Mutagenesis Systems, by Application USD Million (2015-2020)
  • Table 47. India Site Directed Mutagenesis Systems, by End-users USD Million (2015-2020)
  • Table 48. India Site Directed Mutagenesis Systems, by Device USD Million (2015-2020)
  • Table 49. South Korea Site Directed Mutagenesis Systems, by Type USD Million (2015-2020)
  • Table 50. South Korea Site Directed Mutagenesis Systems, by Application USD Million (2015-2020)
  • Table 51. South Korea Site Directed Mutagenesis Systems, by End-users USD Million (2015-2020)
  • Table 52. South Korea Site Directed Mutagenesis Systems, by Device USD Million (2015-2020)
  • Table 53. Taiwan Site Directed Mutagenesis Systems, by Type USD Million (2015-2020)
  • Table 54. Taiwan Site Directed Mutagenesis Systems, by Application USD Million (2015-2020)
  • Table 55. Taiwan Site Directed Mutagenesis Systems, by End-users USD Million (2015-2020)
  • Table 56. Taiwan Site Directed Mutagenesis Systems, by Device USD Million (2015-2020)
  • Table 57. Australia Site Directed Mutagenesis Systems, by Type USD Million (2015-2020)
  • Table 58. Australia Site Directed Mutagenesis Systems, by Application USD Million (2015-2020)
  • Table 59. Australia Site Directed Mutagenesis Systems, by End-users USD Million (2015-2020)
  • Table 60. Australia Site Directed Mutagenesis Systems, by Device USD Million (2015-2020)
  • Table 61. Rest of Asia-Pacific Site Directed Mutagenesis Systems, by Type USD Million (2015-2020)
  • Table 62. Rest of Asia-Pacific Site Directed Mutagenesis Systems, by Application USD Million (2015-2020)
  • Table 63. Rest of Asia-Pacific Site Directed Mutagenesis Systems, by End-users USD Million (2015-2020)
  • Table 64. Rest of Asia-Pacific Site Directed Mutagenesis Systems, by Device USD Million (2015-2020)
  • Table 65. Europe Site Directed Mutagenesis Systems, by Country USD Million (2015-2020)
  • Table 66. Europe Site Directed Mutagenesis Systems, by Type USD Million (2015-2020)
  • Table 67. Europe Site Directed Mutagenesis Systems, by Application USD Million (2015-2020)
  • Table 68. Europe Site Directed Mutagenesis Systems, by End-users USD Million (2015-2020)
  • Table 69. Europe Site Directed Mutagenesis Systems, by Device USD Million (2015-2020)
  • Table 70. Germany Site Directed Mutagenesis Systems, by Type USD Million (2015-2020)
  • Table 71. Germany Site Directed Mutagenesis Systems, by Application USD Million (2015-2020)
  • Table 72. Germany Site Directed Mutagenesis Systems, by End-users USD Million (2015-2020)
  • Table 73. Germany Site Directed Mutagenesis Systems, by Device USD Million (2015-2020)
  • Table 74. France Site Directed Mutagenesis Systems, by Type USD Million (2015-2020)
  • Table 75. France Site Directed Mutagenesis Systems, by Application USD Million (2015-2020)
  • Table 76. France Site Directed Mutagenesis Systems, by End-users USD Million (2015-2020)
  • Table 77. France Site Directed Mutagenesis Systems, by Device USD Million (2015-2020)
  • Table 78. Italy Site Directed Mutagenesis Systems, by Type USD Million (2015-2020)
  • Table 79. Italy Site Directed Mutagenesis Systems, by Application USD Million (2015-2020)
  • Table 80. Italy Site Directed Mutagenesis Systems, by End-users USD Million (2015-2020)
  • Table 81. Italy Site Directed Mutagenesis Systems, by Device USD Million (2015-2020)
  • Table 82. United Kingdom Site Directed Mutagenesis Systems, by Type USD Million (2015-2020)
  • Table 83. United Kingdom Site Directed Mutagenesis Systems, by Application USD Million (2015-2020)
  • Table 84. United Kingdom Site Directed Mutagenesis Systems, by End-users USD Million (2015-2020)
  • Table 85. United Kingdom Site Directed Mutagenesis Systems, by Device USD Million (2015-2020)
  • Table 86. Netherlands Site Directed Mutagenesis Systems, by Type USD Million (2015-2020)
  • Table 87. Netherlands Site Directed Mutagenesis Systems, by Application USD Million (2015-2020)
  • Table 88. Netherlands Site Directed Mutagenesis Systems, by End-users USD Million (2015-2020)
  • Table 89. Netherlands Site Directed Mutagenesis Systems, by Device USD Million (2015-2020)
  • Table 90. Rest of Europe Site Directed Mutagenesis Systems, by Type USD Million (2015-2020)
  • Table 91. Rest of Europe Site Directed Mutagenesis Systems, by Application USD Million (2015-2020)
  • Table 92. Rest of Europe Site Directed Mutagenesis Systems, by End-users USD Million (2015-2020)
  • Table 93. Rest of Europe Site Directed Mutagenesis Systems, by Device USD Million (2015-2020)
  • Table 94. MEA Site Directed Mutagenesis Systems, by Country USD Million (2015-2020)
  • Table 95. MEA Site Directed Mutagenesis Systems, by Type USD Million (2015-2020)
  • Table 96. MEA Site Directed Mutagenesis Systems, by Application USD Million (2015-2020)
  • Table 97. MEA Site Directed Mutagenesis Systems, by End-users USD Million (2015-2020)
  • Table 98. MEA Site Directed Mutagenesis Systems, by Device USD Million (2015-2020)
  • Table 99. Middle East Site Directed Mutagenesis Systems, by Type USD Million (2015-2020)
  • Table 100. Middle East Site Directed Mutagenesis Systems, by Application USD Million (2015-2020)
  • Table 101. Middle East Site Directed Mutagenesis Systems, by End-users USD Million (2015-2020)
  • Table 102. Middle East Site Directed Mutagenesis Systems, by Device USD Million (2015-2020)
  • Table 103. Africa Site Directed Mutagenesis Systems, by Type USD Million (2015-2020)
  • Table 104. Africa Site Directed Mutagenesis Systems, by Application USD Million (2015-2020)
  • Table 105. Africa Site Directed Mutagenesis Systems, by End-users USD Million (2015-2020)
  • Table 106. Africa Site Directed Mutagenesis Systems, by Device USD Million (2015-2020)
  • Table 107. North America Site Directed Mutagenesis Systems, by Country USD Million (2015-2020)
  • Table 108. North America Site Directed Mutagenesis Systems, by Type USD Million (2015-2020)
  • Table 109. North America Site Directed Mutagenesis Systems, by Application USD Million (2015-2020)
  • Table 110. North America Site Directed Mutagenesis Systems, by End-users USD Million (2015-2020)
  • Table 111. North America Site Directed Mutagenesis Systems, by Device USD Million (2015-2020)
  • Table 112. United States Site Directed Mutagenesis Systems, by Type USD Million (2015-2020)
  • Table 113. United States Site Directed Mutagenesis Systems, by Application USD Million (2015-2020)
  • Table 114. United States Site Directed Mutagenesis Systems, by End-users USD Million (2015-2020)
  • Table 115. United States Site Directed Mutagenesis Systems, by Device USD Million (2015-2020)
  • Table 116. Canada Site Directed Mutagenesis Systems, by Type USD Million (2015-2020)
  • Table 117. Canada Site Directed Mutagenesis Systems, by Application USD Million (2015-2020)
  • Table 118. Canada Site Directed Mutagenesis Systems, by End-users USD Million (2015-2020)
  • Table 119. Canada Site Directed Mutagenesis Systems, by Device USD Million (2015-2020)
  • Table 120. Mexico Site Directed Mutagenesis Systems, by Type USD Million (2015-2020)
  • Table 121. Mexico Site Directed Mutagenesis Systems, by Application USD Million (2015-2020)
  • Table 122. Mexico Site Directed Mutagenesis Systems, by End-users USD Million (2015-2020)
  • Table 123. Mexico Site Directed Mutagenesis Systems, by Device USD Million (2015-2020)
  • Table 124. Company Basic Information, Sales Area and Its Competitors
  • Table 125. Company Basic Information, Sales Area and Its Competitors
  • Table 126. Company Basic Information, Sales Area and Its Competitors
  • Table 127. Company Basic Information, Sales Area and Its Competitors
  • Table 128. Company Basic Information, Sales Area and Its Competitors
  • Table 129. Site Directed Mutagenesis Systems: by Type(USD Million)
  • Table 130. Site Directed Mutagenesis Systems Single site directed mutagenesis , by Region USD Million (2021-2026)
  • Table 131. Site Directed Mutagenesis Systems Multiple site directed mutagenesis , by Region USD Million (2021-2026)
  • Table 132. Site Directed Mutagenesis Systems: by Application(USD Million)
  • Table 133. Site Directed Mutagenesis Systems Cancer , by Region USD Million (2021-2026)
  • Table 134. Site Directed Mutagenesis Systems Diabetes , by Region USD Million (2021-2026)
  • Table 135. Site Directed Mutagenesis Systems Cystic fibrosis , by Region USD Million (2021-2026)
  • Table 136. Site Directed Mutagenesis Systems: by End-users(USD Million)
  • Table 137. Site Directed Mutagenesis Systems Research institutes , by Region USD Million (2021-2026)
  • Table 138. Site Directed Mutagenesis Systems Hospitals , by Region USD Million (2021-2026)
  • Table 139. Site Directed Mutagenesis Systems Diagnostic Laboratories , by Region USD Million (2021-2026)
  • Table 140. Site Directed Mutagenesis Systems: by Device(USD Million)
  • Table 141. Site Directed Mutagenesis Systems Real time PCR , by Region USD Million (2021-2026)
  • Table 142. Site Directed Mutagenesis Systems Inverse PCR , by Region USD Million (2021-2026)
  • Table 143. South America Site Directed Mutagenesis Systems, by Country USD Million (2021-2026)
  • Table 144. South America Site Directed Mutagenesis Systems, by Type USD Million (2021-2026)
  • Table 145. South America Site Directed Mutagenesis Systems, by Application USD Million (2021-2026)
  • Table 146. South America Site Directed Mutagenesis Systems, by End-users USD Million (2021-2026)
  • Table 147. South America Site Directed Mutagenesis Systems, by Device USD Million (2021-2026)
  • Table 148. Brazil Site Directed Mutagenesis Systems, by Type USD Million (2021-2026)
  • Table 149. Brazil Site Directed Mutagenesis Systems, by Application USD Million (2021-2026)
  • Table 150. Brazil Site Directed Mutagenesis Systems, by End-users USD Million (2021-2026)
  • Table 151. Brazil Site Directed Mutagenesis Systems, by Device USD Million (2021-2026)
  • Table 152. Argentina Site Directed Mutagenesis Systems, by Type USD Million (2021-2026)
  • Table 153. Argentina Site Directed Mutagenesis Systems, by Application USD Million (2021-2026)
  • Table 154. Argentina Site Directed Mutagenesis Systems, by End-users USD Million (2021-2026)
  • Table 155. Argentina Site Directed Mutagenesis Systems, by Device USD Million (2021-2026)
  • Table 156. Rest of South America Site Directed Mutagenesis Systems, by Type USD Million (2021-2026)
  • Table 157. Rest of South America Site Directed Mutagenesis Systems, by Application USD Million (2021-2026)
  • Table 158. Rest of South America Site Directed Mutagenesis Systems, by End-users USD Million (2021-2026)
  • Table 159. Rest of South America Site Directed Mutagenesis Systems, by Device USD Million (2021-2026)
  • Table 160. Asia Pacific Site Directed Mutagenesis Systems, by Country USD Million (2021-2026)
  • Table 161. Asia Pacific Site Directed Mutagenesis Systems, by Type USD Million (2021-2026)
  • Table 162. Asia Pacific Site Directed Mutagenesis Systems, by Application USD Million (2021-2026)
  • Table 163. Asia Pacific Site Directed Mutagenesis Systems, by End-users USD Million (2021-2026)
  • Table 164. Asia Pacific Site Directed Mutagenesis Systems, by Device USD Million (2021-2026)
  • Table 165. China Site Directed Mutagenesis Systems, by Type USD Million (2021-2026)
  • Table 166. China Site Directed Mutagenesis Systems, by Application USD Million (2021-2026)
  • Table 167. China Site Directed Mutagenesis Systems, by End-users USD Million (2021-2026)
  • Table 168. China Site Directed Mutagenesis Systems, by Device USD Million (2021-2026)
  • Table 169. Japan Site Directed Mutagenesis Systems, by Type USD Million (2021-2026)
  • Table 170. Japan Site Directed Mutagenesis Systems, by Application USD Million (2021-2026)
  • Table 171. Japan Site Directed Mutagenesis Systems, by End-users USD Million (2021-2026)
  • Table 172. Japan Site Directed Mutagenesis Systems, by Device USD Million (2021-2026)
  • Table 173. India Site Directed Mutagenesis Systems, by Type USD Million (2021-2026)
  • Table 174. India Site Directed Mutagenesis Systems, by Application USD Million (2021-2026)
  • Table 175. India Site Directed Mutagenesis Systems, by End-users USD Million (2021-2026)
  • Table 176. India Site Directed Mutagenesis Systems, by Device USD Million (2021-2026)
  • Table 177. South Korea Site Directed Mutagenesis Systems, by Type USD Million (2021-2026)
  • Table 178. South Korea Site Directed Mutagenesis Systems, by Application USD Million (2021-2026)
  • Table 179. South Korea Site Directed Mutagenesis Systems, by End-users USD Million (2021-2026)
  • Table 180. South Korea Site Directed Mutagenesis Systems, by Device USD Million (2021-2026)
  • Table 181. Taiwan Site Directed Mutagenesis Systems, by Type USD Million (2021-2026)
  • Table 182. Taiwan Site Directed Mutagenesis Systems, by Application USD Million (2021-2026)
  • Table 183. Taiwan Site Directed Mutagenesis Systems, by End-users USD Million (2021-2026)
  • Table 184. Taiwan Site Directed Mutagenesis Systems, by Device USD Million (2021-2026)
  • Table 185. Australia Site Directed Mutagenesis Systems, by Type USD Million (2021-2026)
  • Table 186. Australia Site Directed Mutagenesis Systems, by Application USD Million (2021-2026)
  • Table 187. Australia Site Directed Mutagenesis Systems, by End-users USD Million (2021-2026)
  • Table 188. Australia Site Directed Mutagenesis Systems, by Device USD Million (2021-2026)
  • Table 189. Rest of Asia-Pacific Site Directed Mutagenesis Systems, by Type USD Million (2021-2026)
  • Table 190. Rest of Asia-Pacific Site Directed Mutagenesis Systems, by Application USD Million (2021-2026)
  • Table 191. Rest of Asia-Pacific Site Directed Mutagenesis Systems, by End-users USD Million (2021-2026)
  • Table 192. Rest of Asia-Pacific Site Directed Mutagenesis Systems, by Device USD Million (2021-2026)
  • Table 193. Europe Site Directed Mutagenesis Systems, by Country USD Million (2021-2026)
  • Table 194. Europe Site Directed Mutagenesis Systems, by Type USD Million (2021-2026)
  • Table 195. Europe Site Directed Mutagenesis Systems, by Application USD Million (2021-2026)
  • Table 196. Europe Site Directed Mutagenesis Systems, by End-users USD Million (2021-2026)
  • Table 197. Europe Site Directed Mutagenesis Systems, by Device USD Million (2021-2026)
  • Table 198. Germany Site Directed Mutagenesis Systems, by Type USD Million (2021-2026)
  • Table 199. Germany Site Directed Mutagenesis Systems, by Application USD Million (2021-2026)
  • Table 200. Germany Site Directed Mutagenesis Systems, by End-users USD Million (2021-2026)
  • Table 201. Germany Site Directed Mutagenesis Systems, by Device USD Million (2021-2026)
  • Table 202. France Site Directed Mutagenesis Systems, by Type USD Million (2021-2026)
  • Table 203. France Site Directed Mutagenesis Systems, by Application USD Million (2021-2026)
  • Table 204. France Site Directed Mutagenesis Systems, by End-users USD Million (2021-2026)
  • Table 205. France Site Directed Mutagenesis Systems, by Device USD Million (2021-2026)
  • Table 206. Italy Site Directed Mutagenesis Systems, by Type USD Million (2021-2026)
  • Table 207. Italy Site Directed Mutagenesis Systems, by Application USD Million (2021-2026)
  • Table 208. Italy Site Directed Mutagenesis Systems, by End-users USD Million (2021-2026)
  • Table 209. Italy Site Directed Mutagenesis Systems, by Device USD Million (2021-2026)
  • Table 210. United Kingdom Site Directed Mutagenesis Systems, by Type USD Million (2021-2026)
  • Table 211. United Kingdom Site Directed Mutagenesis Systems, by Application USD Million (2021-2026)
  • Table 212. United Kingdom Site Directed Mutagenesis Systems, by End-users USD Million (2021-2026)
  • Table 213. United Kingdom Site Directed Mutagenesis Systems, by Device USD Million (2021-2026)
  • Table 214. Netherlands Site Directed Mutagenesis Systems, by Type USD Million (2021-2026)
  • Table 215. Netherlands Site Directed Mutagenesis Systems, by Application USD Million (2021-2026)
  • Table 216. Netherlands Site Directed Mutagenesis Systems, by End-users USD Million (2021-2026)
  • Table 217. Netherlands Site Directed Mutagenesis Systems, by Device USD Million (2021-2026)
  • Table 218. Rest of Europe Site Directed Mutagenesis Systems, by Type USD Million (2021-2026)
  • Table 219. Rest of Europe Site Directed Mutagenesis Systems, by Application USD Million (2021-2026)
  • Table 220. Rest of Europe Site Directed Mutagenesis Systems, by End-users USD Million (2021-2026)
  • Table 221. Rest of Europe Site Directed Mutagenesis Systems, by Device USD Million (2021-2026)
  • Table 222. MEA Site Directed Mutagenesis Systems, by Country USD Million (2021-2026)
  • Table 223. MEA Site Directed Mutagenesis Systems, by Type USD Million (2021-2026)
  • Table 224. MEA Site Directed Mutagenesis Systems, by Application USD Million (2021-2026)
  • Table 225. MEA Site Directed Mutagenesis Systems, by End-users USD Million (2021-2026)
  • Table 226. MEA Site Directed Mutagenesis Systems, by Device USD Million (2021-2026)
  • Table 227. Middle East Site Directed Mutagenesis Systems, by Type USD Million (2021-2026)
  • Table 228. Middle East Site Directed Mutagenesis Systems, by Application USD Million (2021-2026)
  • Table 229. Middle East Site Directed Mutagenesis Systems, by End-users USD Million (2021-2026)
  • Table 230. Middle East Site Directed Mutagenesis Systems, by Device USD Million (2021-2026)
  • Table 231. Africa Site Directed Mutagenesis Systems, by Type USD Million (2021-2026)
  • Table 232. Africa Site Directed Mutagenesis Systems, by Application USD Million (2021-2026)
  • Table 233. Africa Site Directed Mutagenesis Systems, by End-users USD Million (2021-2026)
  • Table 234. Africa Site Directed Mutagenesis Systems, by Device USD Million (2021-2026)
  • Table 235. North America Site Directed Mutagenesis Systems, by Country USD Million (2021-2026)
  • Table 236. North America Site Directed Mutagenesis Systems, by Type USD Million (2021-2026)
  • Table 237. North America Site Directed Mutagenesis Systems, by Application USD Million (2021-2026)
  • Table 238. North America Site Directed Mutagenesis Systems, by End-users USD Million (2021-2026)
  • Table 239. North America Site Directed Mutagenesis Systems, by Device USD Million (2021-2026)
  • Table 240. United States Site Directed Mutagenesis Systems, by Type USD Million (2021-2026)
  • Table 241. United States Site Directed Mutagenesis Systems, by Application USD Million (2021-2026)
  • Table 242. United States Site Directed Mutagenesis Systems, by End-users USD Million (2021-2026)
  • Table 243. United States Site Directed Mutagenesis Systems, by Device USD Million (2021-2026)
  • Table 244. Canada Site Directed Mutagenesis Systems, by Type USD Million (2021-2026)
  • Table 245. Canada Site Directed Mutagenesis Systems, by Application USD Million (2021-2026)
  • Table 246. Canada Site Directed Mutagenesis Systems, by End-users USD Million (2021-2026)
  • Table 247. Canada Site Directed Mutagenesis Systems, by Device USD Million (2021-2026)
  • Table 248. Mexico Site Directed Mutagenesis Systems, by Type USD Million (2021-2026)
  • Table 249. Mexico Site Directed Mutagenesis Systems, by Application USD Million (2021-2026)
  • Table 250. Mexico Site Directed Mutagenesis Systems, by End-users USD Million (2021-2026)
  • Table 251. Mexico Site Directed Mutagenesis Systems, by Device USD Million (2021-2026)
  • Table 252. Research Programs/Design for This Report
  • Table 253. Key Data Information from Secondary Sources
  • Table 254. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Site Directed Mutagenesis Systems: by Type USD Million (2015-2020)
  • Figure 5. Global Site Directed Mutagenesis Systems: by Application USD Million (2015-2020)
  • Figure 6. Global Site Directed Mutagenesis Systems: by End-users USD Million (2015-2020)
  • Figure 7. Global Site Directed Mutagenesis Systems: by Device USD Million (2015-2020)
  • Figure 8. South America Site Directed Mutagenesis Systems Share (%), by Country
  • Figure 9. Asia Pacific Site Directed Mutagenesis Systems Share (%), by Country
  • Figure 10. Europe Site Directed Mutagenesis Systems Share (%), by Country
  • Figure 11. MEA Site Directed Mutagenesis Systems Share (%), by Country
  • Figure 12. North America Site Directed Mutagenesis Systems Share (%), by Country
  • Figure 13. Global Site Directed Mutagenesis Systems share by Players 2020 (%)
  • Figure 14. BCG Matrix for key Companies
  • Figure 15. Thermo Fisher Scientific (United States) Revenue, Net Income and Gross profit
  • Figure 16. Thermo Fisher Scientific (United States) Revenue: by Geography 2020
  • Figure 17. Takara Bio Inc. (Japan) Revenue, Net Income and Gross profit
  • Figure 18. Takara Bio Inc. (Japan) Revenue: by Geography 2020
  • Figure 19. Genomax Technologies Pvt. Ltd. (Singapore) Revenue, Net Income and Gross profit
  • Figure 20. Genomax Technologies Pvt. Ltd. (Singapore) Revenue: by Geography 2020
  • Figure 21. Agilent Technologies Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 22. Agilent Technologies Inc. (United States) Revenue: by Geography 2020
  • Figure 23. Transgen Biotech Co. Ltd (Japan) Revenue, Net Income and Gross profit
  • Figure 24. Transgen Biotech Co. Ltd (Japan) Revenue: by Geography 2020
  • Figure 25. Global Site Directed Mutagenesis Systems: by Type USD Million (2021-2026)
  • Figure 26. Global Site Directed Mutagenesis Systems: by Application USD Million (2021-2026)
  • Figure 27. Global Site Directed Mutagenesis Systems: by End-users USD Million (2021-2026)
  • Figure 28. Global Site Directed Mutagenesis Systems: by Device USD Million (2021-2026)
  • Figure 29. South America Site Directed Mutagenesis Systems Share (%), by Country
  • Figure 30. Asia Pacific Site Directed Mutagenesis Systems Share (%), by Country
  • Figure 31. Europe Site Directed Mutagenesis Systems Share (%), by Country
  • Figure 32. MEA Site Directed Mutagenesis Systems Share (%), by Country
  • Figure 33. North America Site Directed Mutagenesis Systems Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • Thermo Fisher Scientific (United States)
  • Takara Bio Inc. (Japan)
  • Genomax Technologies Pvt. Ltd. (Singapore)
  • Agilent Technologies Inc. (United States)
  • Transgen Biotech Co. Ltd (Japan)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation